Dr. Joel Pedro R. Feitosa (pictured), 28, from Rio de Janeiro, Brazil, has been shown as the deceased volunteer in the Brazilian arm of AstraZeneca and in the coronavirus vaccine trial at the University of Oxford.
A volunteer from the Brazilian branch of AstraZeneca and the Oxford University coronavirus vaccine trial has died, the country’s Health Authority, Anvisa, reported Wednesday.
The G1 Rio of Brazil proved that the player Dr. Joo Pedro R. Feitosa, 28, from Rio de Janeiro.
He reportedly died of coVID-19 headaches, the disease through the virus, on Thursday, October 15.
Reports imply that Feitosa is not part of the organization that won the vaccine, and resources told Reuters that if it had been, the trial would have been suspended.
Oxford said the trial would continue after the volunteer’s death, adding that an independent had not discovered any protection issues.
“Following a thorough assessment of this case in Brazil, there was no fear about the protection of the clinical trial and independent review in addition to the Brazilian regulator that the trial should continue,” a university spokesman said in a statement.
In an NBC News statement, AstraZeneca also showed that the trial would continue.
“We cannot comment on individual cases in an ongoing Oxford vaccine trial, as we adhere strictly to medical secrecy and clinical trial regulations, but we can verify that all required review processes have been followed,” he said.
“All medical occasions are thoroughly evaluated through verification researchers, an independent protection oversight committee and regulatory authorities. These evaluations did not raise any considerations for the continuation of the ongoing study. “
Reports imply that he was not in the organization that won the experimental vaccine and died of COVID-19 headaches on October 15 and parasitic diseases and vaccines in Sao Paulo, Brazil, on July 24.
Oxford and Brazilian fitness authority Anvisa say it will continue and that there are no protection issues. Photo: AstraZeneca offices in Macclesfield, Cheshire, England, 21 July
Anvisa told FocusOn News that she learned of Feitosa’s death on October 19, an investigation conducted through the International Security Assessment Committee.
It is vitally important to note that, on the basis of the moral confidentiality commitments provided for in the protocol, the regulatory bodies concerned gain partial knowledge similar to the investigation carried out through this committee, which advised further examination, so that the procedure remains under evaluation.
As a result, Anvisa reaffirms that, in accordance with national and foreign regulations of intelligent clinical practice, the knowledge of clinical study volunteers must remain confidential, in accordance with the principles of confidentiality, human dignity and coverage of participants. “
The Federal University of Rio de Janeiro, of which Feitosa was a student, issued a condolence on behalf of her friend and friends.
“Joo, I think in this little text, I can see how exemplary you were as a doctor and student, but I think the reminiscence I’ll mention to everyone here will be different.
“I need to keep the memory of how smart you were boyfriend, brother and friend.
Comments below have been moderated.
By posting your comment, you settle for our internal rules.
We will post your comment and link to the story in your Facebook timeline at the same time as it will be posted on MailOnline. To do this, we will link your MailOnline account to your Facebook account. We’ll ask you to verify this for your first Facebook post.
You can use each post if you need it posted to Facebook. Your main Facebook points will be used to provide you with personalized content, marketing and advertising in accordance with our privacy policy.
Edited via Associated Newspapers Ltd
Part of the Daily Mail, The Mail on Sunday and Metro Media Group